Skip to main content
Fig. 1 | Infectious Agents and Cancer

Fig. 1

From: Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation

Fig. 1

Recurrence-free and overall survival of the entire cohort of patients receiving TDF or ETV therapy after LT for HBV-related HCC. TDF = tenofovir disoproxil fumarate; ETV = entecavir; LT = liver transplantation; HBV = hepatitis B virus; HCC = hepatocellular carcinoma. A. Comparison of Recurrence-free Survival in entire cohort. B. Comparison of Overall Survival in entire cohort

Back to article page